Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 11:4:100063.
doi: 10.1016/j.crimmu.2023.100063. eCollection 2023.

Experimental animal models of chronic inflammation

Mahdi Rafiyan  1 , Shaghayegh Sadeghmousavi  1 , Milad Akbarzadeh  1 , Nima Rezaei  2   3   4
Affiliations
Review

Experimental animal models of chronic inflammation

Mahdi Rafiyan et al. Curr Res Immunol. .

Abstract

Inflammation is a general term for a wide variety of both physiological and pathophysiological processes in the body which primarily prevents the body from diseases and helps to remove dead tissues. It has a crucial part in the body immune system. Tissue damage can recruit inflammatory cells and cytokines and induce inflammation. Inflammation can be classified as acute, sub-acute, and chronic. If it remained unresolved and lasted for prolonged periods, it would be considered as chronic inflammation (CI), which consequently exacerbates tissue damage in different organs. CI is the main pathophysiological cause of many disorders such as obesity, diabetes, arthritis, myocardial infarction, and cancer. Thus, it is critical to investigate different mechanisms involved in CI to understand its processes and to find proper anti-inflammatory therapeutic approaches for it. Animal models are one of the most useful tools for study about different diseases and mechanisms in the body, and are important in pharmacological studies to find proper treatments. In this study, we discussed the various experimental animal models that have been used to recreate CI which can help us to enhance the understanding of CI mechanisms in human and contribute to the development of potent new therapies.

Keywords: Animal models; Chronic inflammation (CI); Inflammation; Inflammatory diseases.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Image 1
Graphical abstract
Fig. 1
Fig. 1
A comparison between Acute, subacute, and chronic inflammation. Notice that Subacute inflammation is a state between acute and chronic inflammation and has some features of acute and chronic inflammation.
Fig. 2
Fig. 2
CI causes several diseases due to its related damages. Parts of the figure were drawn by using pictures from Servier Medical Art. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/).
See this image and copyright information in PMC

References

    1. Abd El-Salam M.H., El-Shibiny S. In: Encapsulations. Grumezescu A.M., editor. Academic Press; 2016. 19 - natural biopolymers as nanocarriers for bioactive ingredients used in food industries; pp. 793–829.
    1. Alexander C., Rietschel E.T. Invited review: bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 2001;7(3):167–202. - PubMed
    1. Aoki J.I., Muxel S.M., Zampieri R.A., Müller K.E., Nerland A.H., Floeter-Winter L.M. Differential immune response modulation in early Leishmania amazonensis infection of BALB/c and C57BL/6 macrophages based on transcriptome profiles. Sci. Rep. 2019;9(1) - PMC - PubMed
    1. Armour K.J., Armour K.E., Van't Hof R.J., Reid D.M., Wei X.Q., Liew F.Y., et al. Activation of the inducible nitric oxide synthase pathway contributes to inflammation‐induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum.: Official Journal of the American College of Rheumatology. 2001;44(12):2790–2796. - PubMed
    1. Balga R., Wetterwald A., Portenier J., Dolder S., Mueller C., Hofstetter W. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro. Bone. 2006;39(2):325–335. - PubMed

LinkOut - more resources